Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TPEX/7713 stock hub

TPEX/7713 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/7713is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/7713

In the news

Latest news · TPEX/7713

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E15.2

P25 14.4P50 18P75 31.9

ROE19.2

P25 -16.2P50 0.3P75 9.8

ROIC12

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/7713 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

TWD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	2%
Employees Change Percent	1.01
Enterprise value	TWD 3.7B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Isin	TW0007713000
Last refreshed	2026-05-10
Market cap	TWD 3.1B
Price	TWD 68.9
Price currency	TWD
Sector	Healthcare
Sic	5047
Symbol	tpex/7713
Website	https://www.weleader.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.66%
EV Earnings	17.51x
EV/EBIT	13.98x
EV/EBITDA	9.48x
EV/FCF	36.32x
EV/Sales	3.29x
FCF yield	3.21%
P/B ratio	2.49x
P/E ratio	15.23x
P/S ratio	2.82x
PE Ratio3 Y	17.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.55%
EBITDA Margin	26.09%
FCF margin	9.07%
Gross margin	33.44%
Gross Profit	TWD 371M
Gross Profit Growth	17.27%
Gross Profit Growth Q	34.21%
Gross Profit Growth3 Y	8.34%
Net Income	TWD 208.6M
Net Income Growth	22.53%
Net Income Growth Q	43.62%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Net Income Growth3 Y	10.69%
Pretax Margin	23.53%
Profit Margin	18.8%
Profitable Years	6
ROA	7.34
ROCE	12.95
ROE	19.23
ROIC	11.97
Roic5y	14.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	32.95%
EPS Growth	10.89
EPS Growth Q	20.86
EPS Growth Quarters	4
EPS Growth Years	2
EPS Growth3 Y	-3.6
FCF Growth	-6.94%
FCF Growth Q	135.09%
OCF Growth	12.39%
OCF Growth Q	91.6%
OCF Growth3 Y	3.78%
Revenue Growth	11.92x
Revenue Growth Q	19.07x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	2.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.5
Assets	TWD 2.4B
Cash	TWD 334.7M
Current Assets	TWD 780.4M
Current Liabilities	TWD 432.3M
Debt	TWD 853.1M
Debt EBITDA	TWD 2.21
Debt Equity	TWD 0.68
Debt FCF	TWD 8.48
Equity	TWD 1.3B
Interest Coverage	32.58
Liabilities	TWD 1.2B
Long Term Assets	TWD 1.7B
Long Term Liabilities	TWD 756.6M
Net Cash	TWD -518.4M
Net Cash By Market Cap	TWD -16.54
Net Debt EBITDA	TWD 1.79
Net Debt Equity	TWD 0.41
Net Debt FCF	TWD 5.16
Tangible Book Value	TWD 1.3B
Tangible Book Value Per Share	TWD 27.65
WACC	3.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.81
Inventory Turnover	6.81
Net Working Capital	TWD 109.9M
Quick ratio	1.52
Working Capital	TWD 348.1M
Working Capital Turnover	TWD 4.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.38%
Dividend Growth	21.73%
Dividend Growth Years	2%
Dividend per share	TWD 4.1
Dividend Years	3
Dividend Yield	5.95%
Ex Div Date	2026-03-27
Last Dividend	TWD 4.1
Payout Frequency	Annual
Payout Ratio	73.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	32.92%
200-day SMA	70.6
50-day SMA	69.16
50-day SMA vs 200-day SMA	50under200
All Time High	86
All Time High Change	-19.88%
All Time High Date	2024-12-06
All Time Low	54.2
All Time Low Change	27.12%
All Time Low Date	2025-04-07
ATR	1.12
Beta	0.1
Beta1y	0.1
Beta2y	0.32
Ch YTD	-6.13
High	68.9
High52	83
High52 Date	2025-09-11
High52ch	-16.99%
Low	68.2
Low52	57.5
Low52 Date	2025-06-03
Low52ch	19.83%
Ma50ch	-0.38%
Price vs 200-day SMA	-2.41%
RSI	55.1
RSI Monthly	48.64
RSI Weekly	45.6
Sharpe ratio	1.49x
Sortino ratio	2.93
Total Return	-5.43%
Tr YTD	-0.59
Tr1m	2.53%
Tr1w	2.07%
Tr3m	3.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 261.2M
Operating Income Growth	21.99
Operating Income Growth Q	47.51
Operating Income Growth3 Y	10.3
Operating margin	23.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,183,932%
Net Borrowing	-60,206,000
Shares Insiders	23.89%
Shares Out	45,478,843
Shares Qo Q	12.27%
Shares Yo Y	11.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 98.9M
Average Volume	15,626.65x
Bv Per Share	27.71
CAPEX	TWD -212.7M
Ch1m	2.53
Ch1w	2.07
Ch1y	18.59
Ch3m	-2.27
Ch6m	-6.64
Change	0.44%
Change From Open	1.03
Close	68.6
Days Gap	-0.58
Depreciation Amortization	28,195,000
Dollar Volume	502,970
Earnings Date	2026-05-15
EBIT	TWD 261.2M
EBITDA	TWD 289.4M
EPS	TWD 4.52
F Score	6
FCF	TWD 100.6M
FCF EV Yield	2.75x
FCF Per Share	TWD 2.21
Financing CF	24,845,000
Fiscal Year End	December
Founded	1,992
Graham Number	53.10911
Graham Upside	-22.92
Income Tax	TWD 52.4M
Investing CF	-275,398,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2025-12-31
Lynch Fair Value	TWD 48.35
Lynch Upside	-29.83
Ma150	72.18
Ma150ch	-4.55%
Ma20	67.52
Ma20ch	2.05%
Net CF	62,742,000
Next Earnings Date	2026-05-15
Open	68.2
P FCF Ratio	31.16
P OCF Ratio	10
Payment Date	2026-04-27
Position In Range	100
Ppne	1,588,840,000
Price Date	2026-05-08
Price EBITDA	TWD 10.83
Ptbv Ratio	2.49
Relative Volume	0.48x
Revenue	1,109,300,000x
SBC By Revenue	0.15x
Share Based Comp	1,610,000
Tax By Revenue	4.73x
Tax Rate	20.09%
Tr6m	-1.12%
Volume	7,300
Z Score	2.74

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/7713 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.0%

$4.10 annual per share

Payout ratio

+73.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

-5.4%

Next ex-dividend date: 2026-03-27

Performance

TPEX/7713 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/7713?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+23.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+11.4%

Negative means the company is buying back shares.

Technical

TPEX/7713 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.1

Neutral momentum band

Price vs 200-day MA

-2.4%

50/200-day relationship not available

Beta (5Y)

0.10

Less volatile than the market

Sharpe ratio

1.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/7713

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7713 stock rating?

tpex/7713 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7713 analysis?

The full report lives at /stocks/tpex/7713/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7713?

The latest report frames tpex/7713 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7713 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.